I would appreciate a copy, Dr. Mitchell.

 

Thank you

 

 

 

 

 

 

John M. Rozman, CNP, MS, MPH

Nurse Practitioner

Employee Occupational Health

Allina Health

800 E. 28th Street

MS15002

Minneapolis, MN 55407

 

john.rozman@allina.com

 

This email and any files transmitted with it are confidential and are intended solely for the use of the individual or entity to whom they are addressed.  If you are not the intended recipient or the individual responsible for delivering the email to the intended recipient, please be advised that you have received this email in error and that any use, dissemination, forwarding, printing or copying of this email is strictly prohibited.

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Dr Amber H Mitchell
Sent: Wednesday, May 18, 2016 10:07 AM
To: MCOH/EH <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] Chemotherapy/Biotherapy reproductive hazards and staffing policy

 

USP<800> will be implemented in July 2018 based on a combination of guidance from ONS, ASHP, NIOSH, OSHA and others.  For the first time, it covers all healthcare workers with potential exposure to hazardous drugs at any point; compounding, crushing, administering, disposing, transporting, etc.

This chapter applies to all healthcare personnel who handle HD preparations and all entities which store, prepare, transport, or administer HDs (e.g., pharmacies, hospitals and other healthcare institutions, patient treatment clinics, physicians' practice facilities, or veterinarians' offices). Personnel who may potentially be exposed to HDs include, but are not limited to: pharmacists, pharmacy technicians, nurses, physicians, physician assistants, home healthcare workers, veterinarians, and veterinary technicians. 

See section on Medical Surveillance lines 666 and on: http://www.usp.org/sites/default/files/usp_pdf/EN/m7808_pre-post.pdf

 

Here is an example of an action plan (see number 2 below) that may be useful developed by Dr. Marty Polovich and her colleagues.  We just presented it to ONS a few weeks ago at their annual conference in San Antonio.  I’d be happy to send the entire presentation (under separate cover) to anyone who would like it.

 

Specific Requirement

Action Steps

Target Date

Responsible Person

Resources Needed

1.Designate a person to oversee USP<800> compliance

Develop position description

Request applicants

Identify training/ education needs

Identify education source

September 2016

John Smith

XX Committee

Fees: Education/ training

2.Personnel of reproductive capability confirm understanding of risk in writing

Develop policy

Develop form

Develop training/ education plan

Implement policy

December 2016

Susan Jones

Employee Health

XX Committee

 

 

Amber Hogan Mitchell, DrPH, MPH, CPH

President | Executive Director

International Safety Center

PH: +1.713.816.0013

EM: amber.mitchell@internationalsafetycenter.org

Web: www.internationalsafetycenter.org

 

 

From: <Swift>, Melanie Swift <melanie.swift@Vanderbilt.Edu>
Reply-To: MCOH/EH <mcoh-eh@mylist.net>
Date: Wednesday, May 18, 2016 at 9:20 AM
To: MCOH/EH <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] Chemotherapy/Biotherapy reproductive hazards and staffing policy

 

Fundamentally you need a comprehensive program in place that protects all workers and prevents exposure for everyone. We have training, work practices, and PPE in place to protect everyone from exposure, regardless of pregnancy status. Because studies in healthcare workers have shown that biomarkers for cytotoxic drugs in urine correlate directly with measures of environmental contamination, we have a program of routine environmental surveillance with surface wipes to detect trace chemotherapeutic agents. This demonstrates that we have good controls in place and are not having contamination. Staff members who are pregnant may still request a temporary reassignment. These requests are considered through the usual channels for accommodation requests, and may be granted if feasible. This is more for peace of mind than a concern that pregnant women are unsafe in the current environment, given the comprehensive protections in place.

 

 

Melanie Swift, MD

Director, Vanderbilt Occupational Health Clinic

http://occupationalhealth.vanderbilt.edu

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Wendy Stephenson
Sent: Wednesday, May 18, 2016 8:11 AM
To: mcoh-eh@mylist.net
Subject: [MCOH-EH] Chemotherapy/Biotherapy reproductive hazards and staffing policy

 

 

 

I’m reaching out to the group on behalf of one of our member hospitals to find out how other organizations handle the chemotherapy / biotherapy reproductive hazards and staffing of pregnant, conceiving, and/or breastfeeding staff members.  Specifically, what policy or procedure is in place for accommodation or “opting out”.  The issue has recently come up due to adoption of the Lippincott manual online and the more obvious messaging about the hazards with administering drugs of various sorts (not just chemo).

 

 

 

 

PHTS Bar for Email Signature copy

Wendy Stephenson, MS, ARM, CPHRM, CSP

Vice President, Risk Management

WSTEPHENSON@PHTS.COM

D803.461.8388  C803.240.8659

O803.731.5300  F 803.731.2849

201 EXECUTIVE CENTER DRIVE, AIKEN BLDG, SUITE 300, COLUMBIA SC 29210

WWW.PHTS.COM

 


This message contains information that is confidential and may be privileged. Unless you are the addressee (or authorized to receive for the addressee), you may not use, copy or disclose to anyone the message or any information contained in the message. If you have received the message in error, please advise the sender by reply e-mail and delete the message.